Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 121223
Published online Dec 14, 2026. doi: 10.3748/wjg.121223
Published online Dec 14, 2026. doi: 10.3748/wjg.121223
Table 1 Baseline characteristics and incident events of study participants, median (interquartile range)/n (%)
| Characteristics | Training | Internal validation | External validation | P value | Overall |
| n | 762 | 761 | 285 | 1808 | |
| Incident AA | 53 (7.0) | 52 (6.8) | 26 (9.1) | 0.410 | 131 (7.3) |
| Site of incident AA | 0.012 | ||||
| Rectum | 6 (0.8) | 19 (2.5) | 10 (3.5) | 35 (1.9) | |
| Left colon | 28 (3.7) | 14 (1.8) | 6 (2.1) | 48 (2.7) | |
| Right colon | 19 (2.5) | 19 (2.5) | 10 (3.5) | 48 (2.7) | |
| Age (years) | 48 (41, 54) | 47 (40, 53) | 51 (43, 59) | < 0.001 | 48 (41, 54) |
| Female sex | 175 (23.0) | 164 (21.6) | 106 (37.2) | < 0.001 | 445 (24.6) |
| DBP (mmHg) | 74 (66, 82) | 73 (66, 82) | 76 (69, 84) | 0.020 | 74 (66, 82) |
| STK1p (pmol/L) | 0.16 (0.10, 0.24) | 0.16 (0.10, 0.23) | 0.33 (0.17, 0.72) | < 0.001 | 0.17 (0.11, 0.26) |
| FIT positive | 213 (27.95) | 216 (28.38) | 77 (27.0) | 0.908 | 506 (28.0) |
| CYFRA21-1 (μg/L) | 2.00 (1.42, 2.70) | 1.92 (1.44, 2.80) | 1.26 (0.95, 1.42) | < 0.001 | 1.83 (1.26, 2.60) |
| CA19-9 (kU/L) | 6.90 (3.62, 11.08) | 6.72 (3.75, 11.27) | 6.69 (3.50, 11.53) | 0.959 | 6.77 (3.62, 11.24) |
Table 2 Predictors selected by the least absolute shrinkage and selection operator procedure
| Lambda | Number of non-zero coefficient | Cross-validation mean deviance | Variables (A)dded, (R)emoved, or left (U)nchanged lambda | |
| 0.0513 | 1 | 0.5032 | A | STK1p |
| 0.0388 | 2 | 0.4959 | A | CA19-9 |
| 0.0294 | 3 | 0.4938 | A | CYFRA21-1 |
| 0.0268 | 4 | 0.4936 | A | DBP |
| 0.0153 | 5 | 0.4805 | A | Age |
| 0.0088 | 6 | 0.4764 | A | FIT positive |
| 0.00731 | 7 | 0.4762 | A | Sex |
Table 3 Development of a logistic model in the training cohort
| Predictor | Odds ratio | 95%CI | Coefficient | P value |
| Univariate regression | ||||
| STK1p (pmol/L) | 1.69 | 1.10-2.61 | 0.5262 | 0.017 |
| CYFRA21-1 (μg/L) | 1.31 | 1.11-1.56 | 0.2717 | 0.002 |
| DBP (mmHg) | 1.04 | 1.02-1.07 | 0.0407 | 0.001 |
| Age (years) | 1.04 | 1.01-1.08 | 0.0420 | 0.007 |
| CA19-9 (kU/L) | 1.03 | 1.003-1.05 | 0.0265 | 0.026 |
| Female sex | 1.10 | 0.57-2.10 | 0.0929 | 0.779 |
| FIT positive | 1.24 | 0.68-2.25 | 0.2119 | 0.489 |
| Stepwise multivariate regression | ||||
| STK1p (pmol/L) | 1.84 | 1.15-2.94 | 0.6084 | 0.011 |
| CYFRA21-1 (μg/L) | 1.32 | 1.10-1.59 | 0.2794 | 0.003 |
| DBP (mmHg) | 1.04 | 1.01-1.07 | 0.0375 | 0.004 |
| Constant | 0.002 | 0.0002-0.01 | -6.3842 | < 0.001 |
Table 4 Performance of different models for predicting advanced adenoma
| Model | Area under the curve (95%CI) | Threshold | Sensitivity | Specificity |
| Training | ||||
| XGBOOST (probability) | 0.988 (0.980-0.996) | ≥ 50% | 96.23% | 99.86% |
| LASSO (probability) | 0.682 (0.596-0.768) | ≥ 7.43% | 50.94% | 84.77% |
| Decision tree (1 vs 0) | 0.667 (0.602-0.733) | ≥ 1 | 35.85% | 97.60% |
| NNET (1 vs 0) | 0.575 (0.527-0.624) | ≥ 1 | 9.43% | 99.58% |
| SVM (1 vs 0) | 0.519 (0.493-0.545) | ≥ 1 | 3.77% | 100.00% |
| Logistic model (probability) | 0.691 (0.607-0.774) | ≥ 8.87% | 50.94% | 85.47% |
| Internal validation | ||||
| XGBOOST (probability) | 0.825 (0.766-0.883) | ≥ 50% | 63.46% | 99.86% |
| LASSO (probability) | 0.616 (0.538-0.693) | ≥ 7.43% | 26.92% | 83.36% |
| Decision tree (1 vs 0) | 0.546 (0.502-0.590) | ≥ 1 | 11.54% | 97.60% |
| NNET (1 vs 0) | 0.492 (0.488-0.497) | ≥ 1 | 0.00% | 98.45% |
| SVM (1 vs 0) | 0.499 (0.498-0.501) | ≥ 1 | 0.00% | 99.86% |
| Logistic model (probability) | 0.622 (0.545-0.698) | ≥ 8.87% | 26.92% | 84.06% |
| External validation | ||||
| XGBOOST (probability) | 0.767 (0.642-0.892) | ≥ 50% | 61.54% | 90.35% |
| LASSO (probability) | 0.500 (0.500-0.500) | ≥ 7.43% | - | - |
| Decision tree (1 vs 0) | 0.561 (0.477-0.646) | ≥ 1 | 23.08% | 89.19% |
| NNET (1 vs 0) | 0.552 (0.489-0.615) | ≥ 1 | 11.54% | 98.84% |
| SVM (1 vs 0) | 0.500 (0.500-0.500) | ≥ 1 | - | - |
| Logistic model (probability) | 0.706 (0.602-0.809) | ≥ 8.87% | 69.23% | 67.95% |
- Citation: Huang XY, Zhao L, He H, Peng R, Xue H, Lai SM, Wu WX, Qiu XX, Cai XH, He JH, Qin WJ, Zhou WT, Wu WQ, Lin YP. Predicting three-year risk of incident colorectal precancerous conditions using non-invasive predictors and machine-learning algorithms: A multi-center retrospective study. World J Gastroenterol 2026; 32(46): 121223
- URL: https://www.wjgnet.com/1007-9327/full/v32/i46/121223.htm
- DOI: https://dx.doi.org/10.3748/wjg.121223